Full Name
Alexandre Chan
Variants
Chan, A.
Chan, Alexandre
Chan A
 
 
 
Email
gmschal@nus.edu.sg
 

Publications

Results 81-96 of 96 (Search time: 0.017 seconds).

Issue DateTitleAuthor(s)
81Sep-2013Psychometric properties and measurement equivalence of the english and chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancerCheung, Y.T.; Lim, S.R.; Shwe, M.; Tan, Y.P.; Chan, A. 
822018Psychometric properties and measurement equivalence of the Multidimensional Fatigue Syndrome Inventory- Short Form (MFSI-SF) amongst breast cancer and lymphoma patients in SingaporeChan A. ; Lew C.; Wang X.J.; Ng T.; Chae J.-W.; Yeo H.L. ; Shwe M. ; Gan Y.X.
832020Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapyCheng, H.L.; Lopez, V. ; Lam, S.C.; Leung, A.K.T.; Li, Y.C.; Wong, K.H.; Au, J.S.K.; Sundar, R.; Chan, A. ; De Ng, T.R.; Suen, L.K.P.; Chan, C.W.; Yorke, J.; Molassiotis, A.
841-Jun-2019Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapyMolassiotis, A.; Cheng, H.L.; Leung, K.T.; Li, Y.C.; Wong, K.H.; Au, J.S.K.; Sundar, R. ; Chan, A. ; Ng, T.R.D.; Suen, L.K.P.; Chan, C.W.; Yorke, J.; Lopez, V. 
85Apr-2013Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysisTeo, Y.L.; Ho, H.K. ; Chan, A. 
862020Role of exosomes in cancer-related cognitive impairmentKoh, Y.Q.; Tan, C.J.; Toh, Y.L.; Sze, S.K.; Ho, H.K. ; Limoli, C.L.; Chan, A. 
872016Routine primary prophylaxis for febrile neutropenia with biosimilar granulocyte colony-stimulating factor (nivestim) or pegfilgrastim is cost effective in non-Hodgkin lymphoma patients undergoing curative-intent R-CHOP chemotherapyWang X.J.; Tang T.; Farid M.; Quek R.; Tao M.; Lim S.T.; Wee H.L. ; Chan A. 
882015Systematic review of pharmacologic and non-pharmacologic interventions to manage cognitive alterations after chemotherapy for breast cancerChan R.J.; McCarthy A.L.; Devenish J.; Sullivan K.A.; Chan, Alexandre 
89Apr-2007Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patientsChan, A. ; Iannucci, A.; Dager, W.E.
902015The effect of ginger (Zingiber officinale) on platelet aggregation: A systematic literature reviewMarx W.; McKavanagh D.; McCarthy A.L.; Bird R.; Ried K.; Chan A. ; Isenring L.
9120-Mar-2012To SMILE or not: Supportive care mattersChan, A. ; Tang, T.; Ng, T.; Shih, V.; Tay, K.; Tao, M.; Quek, R.; Lim, S.T.
9220-Mar-2012To SMILE or not: Supportive care mattersChan, A. ; Tang, T.; Ng, T.; Shih, V.; Tay, K.; Tao, M.; Quek, R.; Lim, S.T.
93Apr-2009Utilisation review of epoetin alfa in cancer patients at a cancer centre in SingaporeChan, A. ; Lim, L.L.C.; Tao, M.
941-Feb-2012Utilizing mobile networks for the detection of clinically relevant interactions between chemotherapy regimens and complementary and alternative medicinesYap, K.Y.-L.; See, C.S.; Kuo, E.Y.; Chui, W.K. ; Chan, A. 
95Jan-2014Vascular endothelial growth factor inhibitors and cognitive impairment: Evidence and controversiesNg, T.; Cheung, Y.T.; Ng, Q.S.; Ho, H.K. ; Chan, A. 
96Jun-2013Visualizing clinical predictors of febrile neutropenia in Asian cancer patients receiving myelosuppressive chemotherapyChen, C.; Chan, A. ; Yap, K.